Paris, France · Founded 2010 · Privately Held (backing)
Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. HighLife is based in Paris, France and was founded in 2010. It was valued at $534 million at its later-stage round in Sep 2026, the last priced event on record. It has raised $71 million across 1 recorded round; the latest was a $90 million later-stage round in Sep 2026.
PMV mark · valuation
$534.1M
Oct 2026
Priced at
its later-stage round
Sep 2026
Total raised
$71.0M
Last round
Later Stage VC
Sep 2026
Team — not yet on record
No current team members for HighLife are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HighLife with a free account
·The post-money valuation on its round
·The complete investor list: 14 names
·Watch HighLife: the Monday email on marks, rounds and moves
